Semisynthetic bile acid shows promise in reducing gut inflammation
A research team from the Medical University of Vienna has made further progress in the treatment of intestinal inflammation.
Johns Hopkins Biomedical Engineering8 天
NIH award supports research on the behaviors of diseased and healthy cells
Jude Phillip, assistant professor in the Department of Biomedical Engineering, received an R35 MIRA award from the National Institutes of Health.
Fred Hutch2 年
Joshua Veatch, MD, PhD
He studies how tumor-recognizing T cells — a type of immune cell — respond to these solid tumors, and how to improve those responses to help patients. One research focus is on CD4, or "helper" T cells ...
来自MSN24 天
Immune response that may stop breast cancer from spreading identified
More information: Ganesan Ramamoorthi et al, Antitumor CD4+ T helper 1 cells target and control the outgrowth of disseminated cancer cells, Cancer Immunology Research (2025). DOI: 10.1158/2326 ...
The New England Journal of Medicine1 个月
CAR+ T-Cell Lymphoma after Cilta-cel Therapy for Relapsed or Refractory Myeloma
Panel E shows the flow cytometric analysis of peripheral blood on day 162. Panel F shows the CAR+CD4−CD8− T-cell counts in peripheral blood (blue line) and bone marrow (purple stars ...
Business Wire15 天
Kairos Pharma Presents Preclinical Data on its Investigational Compounds KROS 101 and KROS ...
The same team of scientists also showed that KROS 101 increased the proliferation of helper and cytotoxic T cells (CD4+ and CD8+), while decreasing T reg cell growth in a melanoma model.